Abstract: Total synthesis campaigns toward complex heterocyclic natural products are a prime source of inspiration for the design and execution of complex cascade sequences, powerful reactions, and efficient synthetic strategies. We highlight selected examples of such innovations in the course of our total syntheses of diazonamide A, azaspiracid-1, thiostrepton, 2,2'-epi-cytoskyrin A and rugulosin, abyssomicin C, platensimycin, and uncialamycin.
INTRODUCTION
Complex natural products have always served as a prime source of inspiration for the synthetic organic chemist and continue to do so to this day. The seemingly limitless structural variations of the secondary metabolites found in nature provide a wealth of synthetic challenges that play a major role in developing and testing the universe of strategies and reactions available for the synthesis of complex organic molecules.
In recent years, our laboratory has been inspired by a diverse array of heterocyclic natural products. Their beautiful molecular architectures provided us with opportunities to ponder their biosynthesis, design complex cascade sequences [1] , apply powerful reactions, and devise efficient strategies for their construction. Among the many target molecules that have inspired our research over the last few years are the natural products discussed in this review: diazonamide A (1), azaspiracid-1 (2), thiostrepton (3), 2,2'-epi-cytoskyrin A (4) and rugulosin (5) , abyssomicin C (6), platensimycin (7) , and uncialamycin (8), all shown in Fig. 1 .
Synthesis of the aminol moiety of the C28-C40 fragment (32) proved to be surprisingly problematic, for initial attempts to promote the cyclization of carbamate 30 to afford protected aminal 31 using Brønsted or Lewis acids were unsuccessful (Scheme 4). Fortunately, extensive screening of Lewis acids ultimately led to the discovery of catalytic Nd(OTf) 3 as a suitable initiator of the required ring closure. Protected aminol 31 was converted into organostannane 32, which was coupled with allylic acetate 29 to yield advanced intermediate 33 [15] , a molecule that contained the entire carbon skeleton of azaspiracid-1. A series of functional group manipulations led to synthetic azaspiracid-1 (2) possessing identical spectroscopic data to those of the authentic substance [12] . Thus, through extensive total synthesis efforts, the structure of this marine toxin was finally fully elucidated. An improved, second-generation total synthesis of azaspiracid-1 was successfully extended to the synthesis of its siblings, azaspiracid-2 and -3 [16] .
Thiostrepton
First isolated in 1954, thiostrepton (3) is the flagship of the thiopeptide class of natural products [17] . It is active against Gram-positive bacteria [18] and Plasmodium falciparum (the parasite responsible for the majority of malaria cases) [19] , and possesses potent immunosuppressive properties [20] . Studies on the biosynthetic origins of thiostrepton have revealed that all structural motifs of the molecule have amino acid origins [21] . Most fascinating, these studies implicated the aza-Diels-Alder reaction in the biogenesis of the dehydropiperidine moiety found at the core of the molecule.
Inspired by the intriguing biosynthesis of the core dehydropiperidine moiety, our strategy for the total synthesis of thiostrepton [22] focused on an aza-Diels-Alder based dimerization of a suitable azadiene system [23] (Scheme 5). Thus, reaction of thiazolidine derivative 34 with Ag 2 CO 3 , DBU, and pyridine (conditions A) led to a transient azadiene (35) whose rapid dimerization furnished, upon selective imine rupture, the desired tetrahydropiperidine intermediate 37 and aldehyde 38, which could be recycled. However, under these conditions, the major product was the complex heterocycle 40, presumably formed by isomerization of intermediate 36 to tautomeric enamine 39 and subsequent aza-Mannich cyclization. With this mechanistic rationale for the formation of undesired product 40 in mind, benzylamine was added (conditions B) to enhance the rate of imine hydrolysis, thus avoiding the undesired pathway. Pleasingly, this simple procedural change led to the suppression of the undesired reaction pathway and an increase of the yield of the desired tetrahydropiperidine product (37) from 22 to 60 %.
With the key construction accomplished, another challenge lay in wait (Scheme 6). Attempted amide coupling of the hindered primary amine in intermediate 37 with protected alanine 41 yielded imine ring-contracted product 42. While the mechanistic course of this undesired reaction was clear, the means to suppress it was not so evident. However, through systematic experimentation, it was discovered that small electrophiles were directly captured by the hindered primary amine without changing the ring size, whereas large electrophiles reacted with concomitant imine ring contraction. Therefore, acid chloride 43 was chosen as a masked alanine unit by virtue of its relatively small size, resulting in the formation of the desired amide bond to yield intermediate 44, which upon further elaboration was successfully transformed into thiostrepton (3) [24] .
2,2'-epi-Cytoskyrin A and rugulosin
The bisanthraquinones are an impressive class of compounds isolated from a variety of fungi and lichens that possess a broad array of biological activities. Structurally, they are characterized by the presence of two identical monomeric units with varying degrees of oxidation and bonding joining them together. Examples of this family of natural products include cytoskyrin A (45) [25] , 2,2'-epi-cytoskyrin A (4) [26] , rugulosin (5) [27], rugulin (46) [28] , and flavoskyrin (47) [27d] (Fig. 3) . Flavoskyrin is the only true heterocyclic compound of this series, but one serving as the precursor of all the others. In the course of our model studies toward cytoskyrin A (45) [29,30b] , it was discovered that all the bonding Subjecting dihydroquinone derivative 48 to the action of MnO 2 followed by the addition of Et 3 N afforded cage-like compound 53 in a single operation. This cascade reaction occurred via oxidation of 48 to quinone derivative 49, which upon enolization and formal hetero-Diels-Alder dimerization yielded isolable intermediate 50. Further MnO 2 -mediated oxidation ruptured the oxygen bridge of 50 to yield intermediate 51, which under the reaction conditions underwent intramolecular Michael addition to yield compound 52. Finally, addition of Et 3 N to the reaction mixture promoted a second intramolecular Michael addition to yield cage-like compound 53. Deprotection of 53 then afforded 2,2'-epi-cytoskyrin A (4).
Likewise, rugulosin (5) was successfully synthesized from dihydroquinone derivative 54. Thus, exposure of the latter compound to MnO 2 and Et 3 N afforded cage-like compound 59 by way of intermediates 55-58. Acid-induced deprotection of compound 59 yielded rugulosin (5) . Altering the choice of hydroxyl protecting group, dihydroquinone derivative 60 was converted to cage-like structure 65 by way of intermediates 61-64. Further oxidation of 65 led to compound 66, which was deprotected to furnish the alleged structure of rugulin (46) . Although X-ray crystallographic analysis of the latter confirmed its structure, its spectroscopic data did not match those reported for the natural substance [28] . In the absence of an authentic sample of the natural product, the true structure of rugulin remains elusive. These studies also led to a family of flavoskyrin-like compounds, including 50, 56, and 62.
Abyssomicin C
In 2004, Süssmuth and Fielder reported the isolation and structural determination of abyssomicin C (6) [31]. Abyssomicin C is the first known natural inhibitor of aminodeoxychorismate synthase and aminodeoxychorismate lyase, enzymes responsible for the biosynthesis of p-aminobenzoic acid (pABA). Abyssomicin C was shown to inhibit the growth of both methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate S. aureus (VISA). The novel mechanism of action and interesting structure of abyssomicin C caught the attention of many synthetic groups [32] , including ours [33] .
Our synthesis of abyssomicin C commenced with a Diels-Alder cycloaddition reaction [34] of diene 67 and methyl acrylate (69) to yield, after spontaneous lactonization, compound 71 (Scheme 8). This cycloaddition, initially promoted by MeMgBr, proved to be problematic, forcing a search for a means of improving the yield of this key step. Extensive screening of conditions ultimately led to the previously undescribed use of aminophenol derivative 68 as a means to improve this reaction.
Presumably, the magnesium cation and the additive serve to template the cycloaddition partners as shown in 70, and in so doing enhance reactivity and stereoselectivity. Intermediate 71 was converted to epoxyacetate 72, which was exposed to LiHMDS to induce a Dieckmann cyclization to intermediate 73. Intermediate 73 was not isolated, but rather was heated with aqueous NH 4 Cl to effect intramolecular attack of the epoxide to yield tricycle 74. The latter compound was found to be somewhat unstable to chromatography and was therefore protected as triethylsilyl (TES) ether 75.
With intermediate 75 in hand, we set about attaching the macrocyclic domain of the molecule (Scheme 9). Thus, lithiation of 75 and acylation with lactone 76 afforded compound 77, which was converted through a short sequence of steps into bis-terminal alkene 78. Ring-closing metathesis [35] within the latter compound afforded macrocyclic system 79. Oxidation and thioketal cleavage led to compound 80, whose spectroscopic data were similar to those of abyssomicin C [31], but not identical. Fortuitously, upon standing in unbuffered CDCl 3 , a 2:1 ratio of abyssomicin C (6) and compound 80 was obtained. X-ray crystallographic analysis of the "mystery" compound revealed its identity as atrop-abyssomicin C (80). This unanticipated atropisomerism would prove to have consequences in reactivity that may lend insight into the biosynthesis of the abyssomicins. Thus, we found that atropabyssomicin C (80) was readily reduced to abyssomicin D (81) [31] , whereas abyssomicin C (6) was reduced, under identical conditions, to afford a compound identified as a diastereoisomer of abyssomicin D. Based on this information, we hypothesized that abyssomicin D (81) may not be biosynthesized from abyssomicin C (6) . Rather, it is likely that both atropisomers of abyssomicin C may be formed in nature, with atrop-abyssomicin C (80) being readily metabolized to abyssomicin D (81).
Our first strategy for an asymmetric synthesis of platensimycin paralleled, to a large extent, our racemic synthesis (Scheme 10). Prochiral eneyne 82 was subjected to a rhodium-catalyzed asymmetric cycloisomerization [39] to yield chiral aldehyde 83 in 91 % yield and ≥95 % e.e. To converge with the racemic route, the ester moiety, which was obligatory for successful rhodium-catalyzed cycloisomerization, had to be excised. Protection of the aldehyde moiety and conversion of the methyl ester moiety into the Barton ester through coupling with pyridine N-oxide derivative 84 afforded intermediate 85.
Radical decarboxylation yielded internal alkene 88, presumably because the initially generated vinyl radical intermediate 86 underwent a 1,3 hydride shift to yield allylic radical 87 before reacting with nBu 3 SnH at the less hindered allylic position, to afford the observed product (88). This unexpected alkene shift was of no consequence, and intermediate 88 was taken through a similar sequence as the one developed for the synthesis of the racemic natural product to give (-)-platensimycin (7).
Alongside our catalytic asymmetric synthesis, we engaged in an alternative asymmetric synthesis of platensimycin wherein the absolute stereochemistry was set by an asymmetric alkylation reaction (Scheme 11). Thus, Myers' alkylation [40] of (S,S)-pseudoephedrine amide 89 with bromide 90 yielded intermediate 91 (in 87 % yield and 99 % d.r. after recrystallization), which was converted into allylsilane derivative 92. Though there was little precedent for the use of non-aromatic carbon nucleophiles in the hypervalent iodine-promoted oxidative dearomatization [41] , we found that this reaction occurred smoothly with substrate 92 and PhI(OAc) 2 to yield, after acetal deprotection, aldehyde 93, an intermediate in our synthesis of racemic platensimycin. This enantioselective total synthesis of (-)-platensimycin (7) was then completed as shown in Scheme 11 through intermediates 94 and 95.
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Scheme 10 Highlights of the first asymmetric synthesis of (-)-platensimycin (7) (catalytic asymmetric method).
Uncialamycin
Uncialamycin (8, Scheme 13) is an enediyne antibiotic reported by the Davies and Andersen groups in 2005 [42] . The small quantity isolated (300 µg) of this naturally occurring substance was enough to allow determination of its extremely potent biological activity against S. aureus (MIC 0.0000064 µg/mL), Escherichia coli (MIC 0.002 µg/mL), and Burkholderia cepacia (MIC 0.001 µg/mL), but not sufficient to complete its structural elucidation. Specifically, the stereochemistry at the C26 stereocenter was not assigned. In light of this situation, we initiated a project directed toward the total synthesis of uncialamycin with the aim of determining its full structure and rendering it available for further biological investigations. Our synthesis of uncialamycin [43] commenced with 5-methoxyisatin (96), which was subjected to a two-step Friedlander quinoline synthesis [44] (Scheme 12). Thus, exposure of 96 to KOH followed by addition of methoxyenone 97 yielded intermediate 98. Base-promoted cycloaromatization of the latter intermediate yielded quinoline carboxylate 99, which was reduced in situ to afford quinoline lactone 100. Swapping the methyl ether for the more readily cleavable 3,4-dimethoxybenzyl (DMB) ether afforded lactone 101.
Lactone 101 was converted into TES-protected lactol 102 as shown in Scheme 13. The pyridine moiety of this intermediate was then activated with AllocCl, and the resulting pyridinium species was trapped with the alkylidene generated from deprotonation of enediyne 103 to yield intermediate 104. A series of functional group manipulations afforded aldehyde 105, which was cyclized by treatment with potassium bis(trimethylsilyl)amide (KHMDS) in the presence of CeCl 3 to furnish 10-membered enediyne system 106, a key intermediate along the synthetic pathway. Conversion of the latter com-pound to iminoquinone 107 made possible a Hauser cyclization utilizing lactone nitrile 108 as a reaction partner to afford, after desilylation, (±)-uncialamycin (8).
An asymmetric version of this total synthesis was subsequently developed in which a modified sequence was employed to prepare enantiomerically pure lactone 101 employing a Noyori reduction [45] of a methyl ketone intermediate.
CONCLUSION
Recent accomplishments in total synthesis highlighted major developments in heterocyclic chemistry and cascade reactions [1] . In this short review, a number of such highlights have been presented which underscore the importance of chemical synthesis in reaching complex molecular architectures defined by nature, assisting in their structural elucidation, and providing them in sufficient quantities for biological investigations. Given that so many interesting organic compounds encountered in nature and in the laboratory are heterocyclic and the fact that such constructs are usually structurally complex and synthetically challenging, the future of heterocyclic chemistry looks brighter than ever. Undoubtedly, major advances in chemistry, biology, and medicine will continue to emerge from endeavors in heterocyclic chemistry, a field that is proliferating as quickly as chemists are able to master its manifold intricacies, and as widely as chemists' imaginations can stretch it [46] [47] [48] .
